@FiercePharma: Branded drug companies deny samples to would-be generics makers. How? REMS, partly. Article | Follow @FiercePharma
@EricPFierce: Merck starts up $120 million China packaging plant but cuts manufacturing operations elsewhere. Story | Follow @EricPFierce
> Takeda Pharmaceutical knew about the possible cancer risks of its diabetes drug Actos 7 years before reporting data to regulators, a lawyer said during the first day of a bellwether trial over the drug. Report
> Swiss biotech Actelion ($ATLN) says it may get back into the black sooner than it had expected after sales of its flagship drug Tracleer beat expectations in the first quarter. Report
> Allergan ($AGN) lost out on FDA approval for Levadex, its inhalable version of a 60-year-old migraine treatment. Report
> Two investors snapped up Pfizer's ($PFE) former research facility in Plattsburgh, NY, with plans to move a Texas manufacturing operation there. Report
> Nestle made a deal with Mexican regulators to approve its acquisition of Pfizer's nutrition business there. Report
@FierceMedDev: At long last, Sony and Olympus launch medical device joint venture. News | Follow @FierceMedDev
@MarkHFierce: The tech behind your old DVD player may have a second life as an HIV Dx tool. Story | Follow @MarkHFierce
@DamianFierce: JNJ CFO says company still "going through the process" of deciding whether to sell/spinoff diagnostics business. | Follow @DamianFierce
> Synthes buy props up weak device sales for J&J. Report
> Panasonic to sell stake in healthcare division. Item
> Is $13.6 Billion too steep for Life Tech? More
> Supreme Court questions validity of Myriad's gene patents. Article
Biotech News
@FierceBiotech: Analysis: 2012 life sciences VC fundraising and new bets shrivel. Article | Follow @FierceBiotech
@RyanMFierce: Eli Lilly reports positive top-line results from 2 PhIIIs of GLP1 drug, but are they positive enough to rival others? Release | Follow @RyanMFierce
> Johnson & Johnson tops pharma rivals in 10-year test of R&D productivity. Report
> Sarepta slips as FDA seeks more data on eteplirsen. News
> Judge turns down motion to appoint examiner or trustee in Biovest bankruptcy case. Report
Pharma Manufacturing News
> U.S. contract manufacturers kick off expansions. Article
> Hospira again names an exec to get manufacturing in order. News
> Bristol-Myers Squibb marries early-stage processes to biologics manufacturing. Article
Biotech Research News
@EmilyMFierce: Is the World's Top Neuroscience Group Quashing Dissent on the U.S. BRAIN Initiative? More | Follow @EmilyMFierce
> Scientists develop technique to rebuild brain cells destroyed by MS, cerebral palsy. Report
> Mersana's cancer drug technology cures tumors in mice at low doses. Story
> New rat model could help scientists better understand, treat Alzheimer's. Article
> Role of brain enzyme linked to neurodegeneration in mice. Item
And Finally... Sanofi ($SNY) fires surprise torpedo at Alzheimer's drug research. Report